{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:40:49Z","timestamp":1790743249825,"version":"4.1.0"},"reference-count":54,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and objective: Parkinson\u2019s disease (PD) is a clinically heterogeneous disorder in which the symptoms and prognosis can be very different among patients. We propose a new simple classification to identify key symptoms and staging in PD. Patients and Methods: Sixteen movement disorders specialists from Spain participated in this project. The classification was consensually approved after a discussion and review process from June to October 2021. The TNM classification and the National Institutes of Health Stroke Scale (NIHSS) were considered as models in the design. Results: The classification was named MNCD and included 4 major axes: (1) motor symptoms; (2) non-motor symptoms; (3) cognition; (4) dependency for activities of daily living (ADL). Motor axis included 4 sub-axes: (1) motor fluctuations; (2) dyskinesia; (3) axial symptoms; (4) tremor. Four other sub-axes were included in the non-motor axis: (1) neuropsychiatric symptoms; (2) autonomic dysfunction; (3) sleep disturbances and fatigue; (4) pain and sensory disorders. According to the MNCD, 5 stages were considered, from stage 1 (no disabling motor or non-motor symptoms with normal cognition and independency for ADL) to 5 (dementia and dependency for basic ADL). Conclusions: A new simple classification of PD is proposed. The MNCD classification includes 4 major axes and 5 stages to identify key symptoms and monitor the evolution of the disease in patients with PD. It is necessary to apply this proof of concept in a properly designed study.<\/jats:p>","DOI":"10.3390\/diagnostics12010055","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T06:55:03Z","timestamp":1640674503000},"page":"55","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["MNCD: A New Tool for Classifying Parkinson\u2019s Disease in Daily Clinical Practice"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-5111","authenticated-orcid":false,"given":"Diego","family":"Santos Garc\u00eda","sequence":"first","affiliation":[{"name":"Unidad de Trastornos de Movimiento, Servicio de Neurolog\u00eda, CHUAC, Complejo Hospitalario Universitario de A Coru\u00f1a, 15009 A Coru\u00f1a, Spain"},{"name":"Neurolog\u00eda, Hospital San Rafael, 15009 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"\u00c1lvarez Sauco","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Hospital General Universitario de Elche, 03203 Elche, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Calopa","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda y Neurofisiolog\u00eda Cl\u00ednica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Roc\u00edo, 41013 Sevilla, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas CIBERNED, 28031 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Escamilla Sevilla","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda, Hospital Universitario Virgen de las Nieves, Instituto de Investigaci\u00f3n Biosanitaria (ibs.Granada), 18013 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Freire","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Hospital General Universitario de Elche, 03203 Elche, Spain"},{"name":"Departamento de Neurolog\u00eda, Hospital IMED Elche, 03203 Elche, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Garc\u00eda Ramos","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria San Carlos (IdISCC), Hospital Cl\u00ednico San Carlos, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas CIBERNED, 28031 Madrid, Spain"},{"name":"Departamento de Neurolog\u00eda, Unidad de Trastornos del Movimiento, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"G\u00f3mez Esteban","sequence":"additional","affiliation":[{"name":"Servicio de Neurolog\u00eda, Hospital Cruces, 48903 Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Legarda","sequence":"additional","affiliation":[{"name":"Hospital Universitario Son Espases, 07120 Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosario Isabel","family":"Luqu\u00edn","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda, Cl\u00ednica Universidad de Navarra, Instituto de Investigaci\u00f3n Sanitaria de Navarra, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7744-6850","authenticated-orcid":false,"given":"Juan Carlos Mart\u00ednez","family":"Castrillo","sequence":"additional","affiliation":[{"name":"Servicio de Neurolog\u00eda, Hospital Ram\u00f3n y Cajal, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mart\u00ednez-Martin","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas CIBERNED, 28031 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mart\u00ednez-Torres","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda, Hospital Universitario y Polit\u00e8cnico La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mir","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda y Neurofisiolog\u00eda Cl\u00ednica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Roc\u00edo, 41013 Sevilla, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas CIBERNED, 28031 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Sesar","family":"Ignacio","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda, CHUS (Complejo Hospitalario Universitario de Santiago de Compostela), 15706 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and Treatment of Parkinson Disease: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: Onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.parkreldis.2019.07.031","article-title":"Non-motor symptoms burden, mood, and gait problems are the most significant factors con-tributing to a poor quality of life in non-demented Parkinson\u2019s disease patients: Results from the COPPADIS Study Cohort","volume":"66","author":"Castro","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ray Chaudhuri, K., Rojo, J.M., Schapira, A.H.V., Brooks, D.J., Stocchi, F., Odin, P., Antonini, A., Brown, R.J., and Martinez-Martin, P. (2013). A proposal for a comprehensive grading of Parkinson\u2019s disease severity combining motor and non-motor assessments: Meeting an unmet need. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057221"},{"key":"ref_7","first-page":"8871549","article-title":"Staging Parkinson\u2019s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life","volume":"2021","author":"Suarez","year":"2021","journal-title":"Parkinsons Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/awx146","article-title":"Progression marker of Parkinson\u2019s disease: A 4-year multi-site imaging study","volume":"140","author":"Burciu","year":"2017","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_10","first-page":"4047392","article-title":"Consensus on the Definition of Advanced Parkinson\u2019s Disease: A Neurologists-Based Delphi Study (CEPA Study)","volume":"2017","author":"Luquin","year":"2017","journal-title":"Park. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41531-018-0056-2","article-title":"Validation of a simple screening tool for early diagnosis of advanced Parkinson\u2019s disease in daily practice: The CDEPA questionnaire","volume":"4","author":"Kulisevsky","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40734-020-00089-4","article-title":"Potential impact and challenges associated with Parkinson\u2019s disease patient care amidst the COVID-19 global pandemic","volume":"7","author":"Elbeddini","year":"2020","journal-title":"J. Clin. Mov. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/nmt-2020-0021","article-title":"Application of the \u20185-2-1\u2019 screening cri-teria in advanced Parkinson\u2019s disease: Interim analysis of DUOGLOBE","volume":"10","author":"Aldred","year":"2020","journal-title":"Neurodegener Dis. Manag."},{"key":"ref_14","first-page":"7537924","article-title":"5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Op-timization of Parkinson\u2019s Treatment","volume":"2020","author":"McAfee","year":"2020","journal-title":"Parkinsons Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.parkreldis.2021.10.009","article-title":"Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson\u2019s disease patients inadequately controlled on oral medications","volume":"92","author":"Antonini","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_16","unstructured":"Sobin, L.H., and Wittekind, C. (1997). TNM Classfication of Malignant Tumors, John Wiley & Sons, Inc.. [5th ed.]."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: A clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic Dysfunction in Parkinson\u2019s Disease","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","article-title":"Parkinson\u2019s disease and sleepiness: An integral part of PD","volume":"58","author":"Arnulf","year":"2002","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/mds.22716","article-title":"Pain in Parkinson\u2019s disease","volume":"25","author":"Ford","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mds.24059","article-title":"Clinical validation of Movement Disorder Socie-ty-recommended diagnostic criteria for Parkinson\u2019s disease with dementia","volume":"27","author":"Barton","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fneur.2012.00088","article-title":"Cognitive impairment and dementia in Parkinson\u2019s disease: Clinical features, diagnosis, and management","volume":"3","author":"Meireles","year":"2012","journal-title":"Front. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: A standardized measure of biological and psycholosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"J. Am. Med. Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"The functional assessment in rehabilitation of elderly people: Self maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.parkreldis.2013.10.027","article-title":"Early DEtection of wEaring off in Parkinson disease: The DEEP study","volume":"20","author":"Stocchi","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/ene.14221","article-title":"Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson\u2019s disease","volume":"27","author":"Castro","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2238-43","DOI":"10.1212\/WNL.0000000000006643","article-title":"Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study","volume":"91","author":"Turcano","year":"2018","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson\u2019s disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1038\/s41598-021-86011-w","article-title":"Risk and mortality of aspiration pneumonia in Parkinson\u2019s disease: A nationwide database study","volume":"11","author":"Won","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Garc\u00eda, D.S., de Deus Fonticoba, T., Cores Bartolom\u00e9, C., Rios, L.N., Garcia Roca, L., Martinez Miro, C., Canfield, H., Maestre, S.J., Aguilar, M., and Pastor, P. (2021). Predictors of Loss of Functional Independence in Parkinson\u2019s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101801"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2559","DOI":"10.1212\/WNL.0000000000007562","article-title":"Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation","volume":"92","author":"Lau","year":"2019","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.04.027","article-title":"PPMI Investigators. How stable are Parkinson\u2019s disease subtypes in de novo patients: Analysis of the PPMI cohort?","volume":"28","author":"Simuni","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1212\/WNL.0000000000005903","article-title":"Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease","volume":"91","author":"Hacker","year":"2018","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1056\/NEJMoa2016311","article-title":"Randomized Trial of Fo-cused Ultrasound Subthalamotomy for Parkinson\u2019s Disease","volume":"383","author":"Shah","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.0.CO;2-Z","article-title":"Mental symptoms in Park-inson\u2019s disease are important contributors to caregiver distress","volume":"14","author":"Aarsland","year":"1999","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson\u2019s disease: A population-based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_41","first-page":"626","article-title":"COPPADIS Study Group. Predictors of Clinically Significant Quality of Life Impairment in Parkinson\u2019s Disease","volume":"11","author":"Cores","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00415-019-09197-0","article-title":"Subjective cognitive decline and progression to dementia in Parkinson\u2019s disease: A long-term follow-up study","volume":"266","author":"Galtier","year":"2019","journal-title":"J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1532-5415.2003.51152.x","article-title":"Loss of Independence in Activities of Daily Living in Older Adults Hospitalized with Medical Illnesses: Increased Vulnerability with Age","volume":"51","author":"Covinsky","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.27177","article-title":"Development and validation of prognostic survival models in newly diagnosed Parkinson\u2019s disease","volume":"33","author":"Macleod","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_46","first-page":"153","article-title":"Unified Parkinson\u2019s Disease Rating Scale","volume":"Volume 2","author":"Fahn","year":"1987","journal-title":"Recent Developments in Parkinson\u2019s Disease"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fnins.2017.00555","article-title":"How Wearable Sensors Can Support Parkinson\u2019s Disease Diagnosis and Treatment: A Systematic Review","volume":"11","author":"Rovini","year":"2017","journal-title":"Front Neurosci."},{"key":"ref_49","first-page":"S41","article-title":"How Mobile Health Technology and Electronic Health Records Will Change Care of Patients with Parkinson\u2019s Disease","volume":"8","author":"Hansen","year":"2018","journal-title":"J. Park. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson\u2019s disease","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41531-021-00228-0","article-title":"Comprehensive subtyping of Parkinson\u2019s disease patients with similarity fusion: A case study with BioFIND data","volume":"7","author":"Brendel","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s Disease: Biomarkers, Treatment, and Risk Factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_53","first-page":"S752","article-title":"Prevalence of advanced Parkinson\u2019s Disease in patients treated in the hospitals of the Spanish public health care system: PARA-DISE Study (interim analysis)","volume":"34","author":"Burgos","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_54","first-page":"9131474","article-title":"Update on the Man-agement of Parkinson\u2019s Disease for General Neurologists","volume":"2020","author":"Bajenaru","year":"2020","journal-title":"Parkinsons Dis."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/1\/55\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:54:39Z","timestamp":1760169279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/1\/55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["diagnostics12010055"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12010055","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}